Wise Will Seek FDA Approval for Digital Anxiety Management Therapy episode artwork

EPISODE · May 17, 2021 · 8 MIN

Wise Will Seek FDA Approval for Digital Anxiety Management Therapy

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses FDA approval for Wise’s digital anxiety management therapy.Also, columnist Jessie Ace reads a column by Jennifer Powell where she describes how her new role of being the caregiver in her relationship makes her feel. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published May 17, 2021

Embed this episode

NOW PLAYING

Wise Will Seek FDA Approval for Digital Anxiety Management Therapy

0:00 8:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 8 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on May 17, 2021.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!